Surgery for Pediatric Cholesteatoma Treatment & Management

  • Author: Peter S Roland, MD; Chief Editor: Glenn C Isaacson, MD, FACS, FAAP   more...
 
Updated: Mar 25, 2010
 

Medical Care

Medical therapy is not an accepted treatment for cholesteatoma. Patients who refuse surgery or those with a medical condition that makes a general anesthetic too hazardous should have the ear cleaned regularly, usually over 2-3 months. Regular cleaning can help control infection and may slow growth, but it does not stop further expansion or eliminate risk. The mainstay of antimicrobial therapy should be topical, but systemic therapy is occasionally a helpful adjunct.

Next

Surgical Care

Surgical therapy consists of removal of the cholesteatoma. As mentioned in History, 2 types of operations are commonly used for the management of cholesteatoma. The open cavity (ie, canal wall down) technique was used exclusively until the House Otologic Group introduced the closed cavity (ie, canal wall up) technique. Various factors are considered in determining which procedure is best in a given circumstance.

Sometimes, this decision cannot be made until the operation has begun and a clear understanding of the extent of disease has been obtained. Open cavity operations have the highest probability of permanently ridding the patient of cholesteatoma. Closed cavity procedures have the advantage of maintaining a normal appearance but have a higher risk of persistent or recurrent cholesteatoma. The risk of persistence is sufficient to cause most surgeons to advise an obligatory "second look" tympanomastoidectomy 6-12 months following the initial operation if a closed cavity procedure is performed.[6] During the second look, traces of residual disease frequently can be removed prior to the development of either complications or massive recurrence.

  • In some circumstances, the surgeon is fairly sure preoperatively which operation (closed or open cavity) to perform, especially in the following situations:[7]
    • If the patient has had several episodes of the cholesteatoma and wishes to avoid future operations, the open cavity technique is most applicable.
    • For patients who are unwilling or unable to return for a second look procedure, an open cavity operation is safer.
    • A large meatoplasty is simply unacceptable under any circumstance for some patients. These patients can be treated with a closed technique if they understand that disease recurrence is more likely and that they may require multiple serial surgical procedures.The photo exhibits a large meatoplasty performed aThe photo exhibits a large meatoplasty performed as part of an open cavity (canal wall down) mastoidectomy. A similar meatoplasty usually is necessary if a clean, dry, problem-free cavity is to be maintained.
  • Some congenital anomalies are known to be associated with a lifelong history of eustachian tube dysfunction. In some individuals, previous surgical procedures have irreversibly injured the eustachian tube. In such individuals, an open cavity operation often is best.
  • Some intraoperative findings favor an open technique:
    • The sinus tympani is involved.
    • The medial end of the canal wall is involved, with the cholesteatoma wedged laterally between the heads of the ossicles in the epitympanum and medial canal wall.
    • Ostitis or irremovable cholesteatoma in the area around the opening to the Eustachian tube or in the most inferior portions of the middle ear space often calls for a true radical mastoidectomy.
    • Although small defects in the canal wall are readily repaired, larger defects are harder to repair. Converting the operation to an open cavity technique is best.
    • Labyrinthine fistula is present. If the cholesteatoma matrix is left over the fistula so as not to expose it, then the canal must be removed. Otherwise, epithelium is trapped within the mastoid cavity, which simply results in cholesteatoma recurrence. If the cholesteatoma matrix is removed from the fistula, some surgeons are comfortable leaving the canal wall up.
  • In the United States, most surgical procedures for cholesteatoma now are performed through an incision behind the ear combined with an incision in the external auditory canal, but the procedure can be performed through an extended incision starting in the canal alone.
  • Regardless of which technique is used, all air cells should be removed. If ossicles are involved, they must be removed to avoid recurrence.[8] The ossicular chain can be reconstructed either at the end of the primary procedure or as part of a secondary operation.
  • The TM is usually reconstructed. If a closed cavity technique is used, missing bone should be replaced with a cartilage graft. If an open cavity procedure is selected, a large meatoplasty should be created to allow adequate air circulation into the cavity that remains.
Previous
Next

Consultations

  • Consultation with an otolaryngologist is mandatory.
  • Rarely, advice from a neurosurgeon is required to help manage an intracranial consultation.
Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Peter S Roland, MD  Professor, Department of Neurological Surgery, Professor and Chairman, Department of Otolaryngology-Head and Neck Surgery, Director of Clinical Center for Auditory, Vestibular and Facial Nerve Disorders, Chief of Pediatric Otology, University of Texas Southwestern Medical Center; Adjunct Professor of Communicative Disorders, University of Texas School of Human Development

Peter S Roland, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American Laryngological Rhinological and Otological Society, American Neurotology Society, American Otological Society, North American Skull Base Society, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Alcon Labs Honoraria Speaking and teaching; GSK Honoraria Speaking and teaching; Advanced Bionics Honoraria Board membership; Cochlear Corp Honoraria Board membership; Med El Corp travel grants Consulting

Specialty Editor Board

Orval Brown, MD  Director of Otolaryngology Clinic, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center at Dallas

Orval Brown, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Medical Association, American Society of Pediatric Otolaryngology, Society for Ear, Nose and Throat Advances in Children, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Pharmacy Editor, eMedicine

Disclosure: Nothing to disclose.

John E McClay, MD  Associate Professor of Pediatric Otolaryngology, Department of Otolaryngology-Head and Neck Surgery, Children's Hospital of Dallas, University of Texas Southwestern Medical School

John E McClay, MD is a member of the following medical societies: American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and American Medical Association

Disclosure: Nothing to disclose.

Paul D Petry, DO, FACOP, FAAP  Consulting Staff, Freeman Pediatric Care, Freeman Health System

Paul D Petry, DO, FACOP, FAAP is a member of the following medical societies: American Academy of Osteopathy, American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association

Disclosure: Nothing to disclose.

Chief Editor

Glenn C Isaacson, MD, FACS, FAAP  Professor of Otolaryngology-Head and Neck Surgery and Pediatrics, Temple University School of Medicine

Glenn C Isaacson, MD, FACS, FAAP is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Society of Pediatric Otolaryngology, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Covidien Honoraria Consulting

References
  1. Roland PS, Meyerhoff WL. Open-cavity tympanomastoidectomy. Otolaryngol Clin North Am. Jun 1999;32(3):525-46. [Medline].

  2. Graham MD, Delap TG, Goldsmith MM. Closed tympanomastoidectomy. Otolaryngol Clin North Am. Jun 1999;32(3):547-54. [Medline].

  3. Manolidis S, Kutz JW Jr. Diagnosis and management of lateral sinus thrombosis. Otol Neurotol. Sep 2005;26(5):1045-51. [Medline].

  4. Kazahaya K, Potsic WP. Congenital cholesteatoma. Curr Opin Otolaryngol Head Neck Surg. Oct 2004;12(5):398-403. [Medline].

  5. Potsic WP, Korman SB, Samadi DS, Wetmore RF. Congenital cholesteatoma: 20 years' experience at The Children's Hospital of Philadelphia. Otolaryngol Head Neck Surg. Apr 2002;126(4):409-14. [Medline].

  6. Dawes PJ, Leaper M. Paediatric small cavity mastoid surgery: second look tympanotomy. Int J Pediatr Otorhinolaryngol. Feb 2004;68(2):143-8. [Medline].

  7. De la Cruz A, Fayad JN. Detection and management of childhood cholesteatoma. Pediatr Ann. Jun 1999;28(6):370-3. [Medline].

  8. Dornhoffer JL, Colvin GB, North P. Evidence of residual disease in ossicles of patients undergoing cholesteatoma removal. Acta Otolaryngol. Jan 1999;119(1):89-92. [Medline].

  9. Busaba NY. Clinical presentation and management of labyrinthine fistula caused by chronic otitis media. Ann Otol Rhinol Laryngol. May 1999;108(5):435-9. [Medline].

  10. Anderson J, Caye-Thomasen P, Tos M. A comparison of cartilage palisades and fascia in tympanoplasty after surgery for sinus or tensa retraction cholesteatoma in children. Otol Neurotol. Nov 2004;25(6):856-63. [Medline].

  11. Bennett M, Warren F, Jackson GC, Kaylie D. Congenital cholesteatoma: theories, facts, and 53 patients. Otolaryngol Clin North Am. Dec 2006;39(6):1081-94. [Medline].

  12. Chadha NK, Jardine A, Owens D, et al. A multivariate analysis of the factors predicting hearing outcome after surgery for cholesteatoma in children. J Laryngol Otol. Nov 2006;120(11):908-13. [Medline].

  13. Golz A, Goldenberg D, Netzer A, et al. Cholesteatomas associated with ventilation tube insertion. Arch Otolaryngol Head Neck Surg. Jul 1999;125(7):754-7. [Medline].

  14. Kemppainen HO, Puhakka HJ, Laippala PJ, et al. Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol. 1999;119(5):568-72. [Medline].

  15. Migirov L, Duvdevani S, Kronenberg J. Otogenic intracranial complications: a review of 28 cases. Acta Otolaryngol. Aug 2005;125(8):819-22. [Medline].

  16. Ottaviani F, Neglia CB, Berti E. Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth?. Acta Otolaryngol. 1999;119(4):462-7. [Medline].

  17. Semaan MT, Megerian CA. The pathophysiology of cholesteatoma. Otolaryngol Clin North Am. Dec 2006;39(6):1143-59. [Medline].

  18. Thompson JW. Cholesteatomas. Pediatr Rev. Apr 1999;20(4):134-6. [Medline].

  19. Tierney PA, Pracy P, Blaney SP, Bowdler DA. An assessment of the value of the preoperative computed tomography scans prior to otoendoscopic 'second look' in intact canal wall mastoid surgery. Clin Otolaryngol Allied Sci. Aug 1999;24(4):274-6. [Medline].

Previous
Next
 
A typical audiogram demonstrating bilateral conductive hearing loss, which may be observed in an individual with a cholesteatoma.
The photo exhibits a large meatoplasty performed as part of an open cavity (canal wall down) mastoidectomy. A similar meatoplasty usually is necessary if a clean, dry, problem-free cavity is to be maintained.
An unenhanced CT scan demonstrating that the posterior canal wall has been eroded and the external auditory canal has filled with cholesteatoma, pus, and debris. Surprisingly, the middle ear appears relatively free of disease, a characteristic of primary acquired cholesteatomas.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.